| Name | Title | Contact Details |
|---|---|---|
Alex Rindels |
Associate General Counsel | Profile |
Fee-free online business banking thats easy to use anywhere. All the features you need, zero fees or hassle.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Infinity is a full-service, high-touch, world-class, dash-happy custom software shop that’s been building (cool) stuff since 1998.
Ontrack provides cutting-edge technology services and products to address your critical information needs with data recovery and data erasure.
Accounting Robots Fastest growing RPA platform in the mid-market Request A Demo Our Most Popular Robots Accounts Receivable Robot- save 6 hours/day Accounts Payable Robot - save 7.5 hours/day Reconciliation Robot - save 2 hours/week Trusted by Industry...